HPV vaccine acceptability in Africa: A systematic review

Preventive Medicine

Volumn 69, Issue , 2014, Pages 274-279

  Cunningham, Melissa S ^a   Davison, Colleen ^a,b   Aronson, Kristan J ^a,c  

^a QUEEN S UNIVERSITY   (Canada)

^b KINGSTON GENERAL HOSPITAL   (Canada)

^c QUEEN S UNIVERSITY   (Canada)

Author keywords

Acceptability; Africa; Attitudes; Human papillomavirus; Review; Vaccination

Indexed keywords

WART VIRUS VACCINE;

AFRICA; AWARENESS; CANCER RISK; DAUGHTER; DISEASE SEVERITY; DRUG COST; DRUG EFFICACY; DRUG INFORMATION; DRUG SAFETY; GOVERNMENT; HEALTH BELIEF MODEL; HEALTH CARE ACCESS; HEALTH CARE DELIVERY; HEALTH CARE PERSONNEL; HUMAN; INFECTION RISK; KNOWLEDGE; META ANALYSIS; PAPILLOMAVIRUS INFECTION; PATIENT ATTITUDE; PATIENT EDUCATION; PEER REVIEW; PREVENTIVE HEALTH SERVICE; PROGRAM ACCEPTABILITY; REVIEW; SOCIAL ACCEPTANCE; SYSTEMATIC REVIEW; UTERINE CERVIX CANCER; VACCINATION; WART VIRUS; ADOLESCENT; ADULT; AFRICA SOUTH OF THE SAHARA; AGED; ATTITUDE TO HEALTH; CHILD; ETHNOLOGY; FEMALE; MALE; MIDDLE AGED; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PSYCHOLOGY; STATISTICS AND NUMERICAL DATA; UTERINE CERVICAL NEOPLASMS; VAGINA SMEAR; VERY ELDERLY; VIROLOGY; YOUNG ADULT;

ADOLESCENT; ADULT; AFRICA SOUTH OF THE SAHARA; AGED; AGED, 80 AND OVER; CHILD; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; MALE; MIDDLE AGED; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS VACCINES; PATIENT ACCEPTANCE OF HEALTH CARE; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS; YOUNG ADULT;

EID: 84909966402     PISSN: 00917435     EISSN: 10960260     Source Type: Journal    
DOI: 10.1016/j.ypmed.2014.08.035     Document Type: Review

References (40)

1. Allen J.D., Coronado G.D., Williams R.S., et al. A systematic review of measures used in studies of human papillomavirus (HPV) vaccine acceptability. Vaccine 2010, 28:4027-4037.
2. Ayissi C.A., Wamai R.G., Oduwo G.O., et al. Awareness, acceptability and uptake of human papilloma virus vaccine among Cameroonian school-attending female adolescents. J. Community Health 2012, 37:1127-1135.
3. Becker-Dreps S., Otieno W.A., Brewer N.T., Agot K., Smith J.S. HPV vaccine acceptability among Kenyan women. Vaccine 2010, 28:4864-4867.
4. Binagwaho A., Wagner C., Gatera M., Karema C., Nutt C., Ngaboa F. Achieving high coverage in Rwanda's national human papillomavirus vaccination programme. Bull. World Health Organ. 2012, 90:623-628.
5. Bosch F.X., de Sanjosé S. Chapter 1: Human papillomavirus and cervical cancer-burden and assessment of causality. JNCI Monogr. 2003, 2003:3-13.
6. Brewer N.T., Fazekas K.I. Predictors of HPV vaccine acceptability: a theory-informed, systematic review. Prev. Med. 2007, 45:107-114.
7. Coleman M.A., Levison J., Sangi-Haghpeykar H. HPV vaccine acceptability in Ghana, West Africa. Vaccine 2011, 29:3945-3950.
8. Cooper L.Z., Larson H.J., Katz S.L. Protecting public trust in immunization. Pediatrics 2008, 122:149-153.
9. DiAngi Y.T., Panozzo C.A., Ramogola-Masire D., Steenhoff A.P., Brewer N.T. A cross-sectional study of HPV vaccine acceptability in Gaborone, Botswana. PLoS ONE 2011, 6:e25481.
10. Dixon-Woods M., Shaw R.L., Agarwal S., Smith J.A. The problem of appraising qualitative research. Qual. Saf. Health Care 2004, 13:223-225.
11. Forman D., de Martel C., Lacey C.J., et al. Global burden of human papillomavirus and related diseases. Vaccine 2012, 30:F12-F23.
12. Francis S.A., Nelson J., Liverpool J., Soogun S., Mofammere N., Thorpe R.J. Examining attitudes and knowledge about HPV and cervical cancer risk among female clinic attendees in Johannesburg, South Africa. Vaccine 2010, 28:8026-8032.
13. Francis S.A., Battle-Fisher M., Liverpool J., et al. A qualitative analysis of South African women's knowledge, attitudes, and beliefs about HPV and cervical cancer prevention, vaccine awareness and acceptance, and maternal-child communication about sexual health. Vaccine 2011, 29:8760-8765.
14. Garnett G.P., Kim J.J., French K., Goldie S.J. Chapter 21: Modelling the impact of HPV vaccines on cervical cancer and screening programmes. Vaccine 2006, 24:S178-S186.
15. GAVI Millions of girls in developing countries to be protected against cervical cancer thanks to new HPV vaccine deals-2013-Press releases-News-Library-GAVI Alliance [WWW Document] URL, (accessed 8.13.13). http://www.gavialliance.org/library/news/press-releases/2013/hpv-price-announcement/.
16. Harries J., Moodley J., Barone M.A., Mall S., Sinanovic E. Preparing for HPV vaccination in South Africa: key challenges and opinions. Vaccine 2009, 27:38-44.
17. Iliyasu Z., Abubakar I.S., Aliyu M.H., Galadanci H.S. Cervical cancer risk perception and predictors of human papilloma virus vaccine acceptance among female university students in northern Nigeria. J. Obstet. Gynaecol. 2010, 30:857-862.
18. Johnson C.E., Mues K.E., Mayne S.L., Kiblawi A.N. Cervical cancer screening among immigrants and ethnic minorities: a systematic review using the health belief model. J. Low Genit. Tract Dis. 2008, 12:232-241.
19. Kane M.A., Sherris J., Coursaget P., Aguado T., Cutts F. Chapter 15: HPV vaccine use in the developing world. Vaccine 2006, 24:S132-S139.
20. Katahoire R.A., Jitta J., Kivumbi G., et al. An assessment of the readiness for introduction of the HPV vaccine in Uganda. Afr. J. Reprod. Health 2008, 12.
21. Ladner J., Besson M.-H., Hampshire R., Tapert L., Chirenje M., Saba J. Assessment of eight HPV vaccination programs implemented in lowest income countries. BMC Public Health 2012, 12:370.
22. LaMontagne D.S., Barge S., Thi Le N., et al. Human papillomavirus vaccine delivery strategies that achieved high coverage in low-and middle-income countries. Bull. World Health Organ. 2011, 89:821-830.
23. Liu F.W., Vwalika B., Hacker M.R., et al. Cervical cancer and HPV vaccination: knowledge and attitudes of adult women in Lusaka, Zambia. J. Vaccines Vaccin. 2012, 03:03.
24. Makwe C.C., Anorlu R.I., Odeyemi K.A. Human papillomavirus (HPV) infection and vaccines: knowledge, attitude and perception among female students at the University of Lagos, Lagos, Nigeria. J. Epidemiol. Glob. Health 2012, 2:199-206.
25. Moodley I., Mubaiwa V., Denny L. High uptake of Gardasil vaccine among 9-12-year-old schoolgirls participating in an HPV vaccination demonstration project in KwaZulu-Natal Province. S. Afr. Med. J. 2013, 103.
26. Omondi-Ogutu, M'Imunya J.M. Parental acceptance of human papilloma virus vaccine for their pre-pubertal and teenage daughters. East Afr. Med. J. 2011, 88:163-170.
27. Palefsky J.M., Gillison M.L., Strickler H.D. Chapter 16: HPV vaccines in immunocompromised women and men. Vaccine 2006, 24:S140-S146.
28. Perlman S., Wamai R., Bain P., et al. Knowledge and awareness of HPV vaccine and acceptability to vaccinate in Sub-Saharan Africa: a systematic review. PLoS ONE 2014, 9:e90912.
29. Poole D.N., Tracy J.K., Levitz L., et al. A cross-sectional study to assess HPV knowledge and HPV vaccine acceptability in Mali. PLoS ONE 2013, 8:e56402.
30. Ports K.A., Reddy D.M., Rameshbabu A. Barriers and facilitators to HPV vaccination: perspectives from Malawian women. Women Health 2013, 53:630-645.
31. Poss J.E. Developing a new model for cross-cultural research: synthesizing the health belief model and the theory of reasoned action. Adv. Nurs. Sci. 2001, 23:1-15.
32. Prematunge C., Corace K., McCarthy A., Nair R.C., Pugsley R., Garber G. Factors influencing pandemic influenza vaccination of healthcare workers-a systematic review. Vaccine 2012, 30:4733-4743.
33. Remes P., Selestine V., Changalucha J., et al. A qualitative study of HPV vaccine acceptability among health workers, teachers, parents, female pupils, and religious leaders in northwest Tanzania. Vaccine 2012, 30:5363-5367.
34. Rondy M., van Lier A., van de Kassteele J., Rust L., de Melker H. Determinants for HPV vaccine uptake in the Netherlands: a multilevel study. Vaccine 2010, 28:2070-2075.
35. Rosenthal S.L., Weiss T.W., Zimet G.D., Ma L., Good M.B., Vichnin M.D. Predictors of HPV vaccine uptake among women aged 19-26: importance of a physician's recommendation. Vaccine 2011, 29:890-895.
36. Rositch A.F., Gatuguta A., Choi R.Y., et al. Knowledge and acceptability of pap smears, self-sampling and HPV vaccination among adult women in Kenya. PLoS ONE 2012, 7:e40766.
37. Sankaranarayanan R., Ferlay J. Worldwide burden of gynaecological cancer: the size of the problem. Best Pract. Res. Clin. Obstet. Gynaecol. 2006, 20:207-225.
38. Sudenga S.L., Rositch A.F., Otieno W.A., Smith J.S. Knowledge, attitudes, practices, and perceived risk of cervical cancer among Kenyan women: brief report. Int. J. Gynecol. Cancer 2013, 23:895-899.
39. Watson-Jones D., Baisley K., Ponsiano R., et al. Human papillomavirus vaccination in Tanzanian schoolgirls: cluster-randomized trial comparing 2 vaccine-delivery strategies. J. Infect. Dis. 2012, 206:678-686.
40. Watson-Jones Deborah, Tomlin K., Remes P., et al. Reasons for receiving or not receiving HPV vaccination in primary schoolgirls in Tanzania: a case control study. PLoS ONE 2012, 7:e45231.